Clinical Trial Detail

NCT ID NCT01943682
Title Safety Study of CPX-351 in Children With Relapsed Leukemia or Lymphoma
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Children's Hospital Medical Center, Cincinnati
Indications

acute lymphoblastic leukemia

lymphoma

acute myeloid leukemia

Therapies

CPX-351

Age Groups: adult child

No variant requirements are available.